These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 30660924)

  • 1. Progressive myoclonus epilepsy caused by a gain-of-function KCNA2 mutation.
    Canafoglia L; Castellotti B; Ragona F; Freri E; Granata T; Chiapparini L; Gellera C; Scaioli V; Franceschetti S; DiFrancesco JC
    Seizure; 2019 Feb; 65():106-108. PubMed ID: 30660924
    [No Abstract]   [Full Text] [Related]  

  • 2. Progressive myoclonic epilepsy: myoclonic epilepsy and ataxia due to KCNC1 mutation (MEAK): a case report and review of the literature.
    Barot N; Margiotta M; Nei M; Skidmore C
    Epileptic Disord; 2020 Oct; 22(5):654-658. PubMed ID: 32972906
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dominant KCNA2 mutation causes episodic ataxia and pharmacoresponsive epilepsy.
    Corbett MA; Bellows ST; Li M; Carroll R; Micallef S; Carvill GL; Myers CT; Howell KB; Maljevic S; Lerche H; Gazina EV; Mefford HC; Bahlo M; Berkovic SF; Petrou S; Scheffer IE; Gecz J
    Neurology; 2016 Nov; 87(19):1975-1984. PubMed ID: 27733563
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ataxia and myoclonic epilepsy due to a heterozygous new mutation in KCNA2: proposal for a new channelopathy.
    Pena SD; Coimbra RL
    Clin Genet; 2015 Feb; 87(2):e1-3. PubMed ID: 25477152
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myoclonus epilepsy and ataxia due to potassium channel mutation (MEAK) is caused by heterozygous KCNC1 mutations.
    Nascimento FA; Andrade DM
    Epileptic Disord; 2016 Sep; 18(S2):135-138. PubMed ID: 27629860
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myoclonus epilepsy and ataxia due to potassium channel mutation (MEAK): a cause of progressive myoclonic epilepsy.
    Mahale RR; Tiwari R; Arunachal G; Padmanabha H; Mailankody P
    Acta Neurol Belg; 2022 Jun; 122(3):801-803. PubMed ID: 33725338
    [No Abstract]   [Full Text] [Related]  

  • 7. A novel variant of dehydrodolichol diphosphate synthase (DHDDS) mutation with adult-onset progressive myoclonus ataxia.
    Kim J; Kim I; Koh SB
    Parkinsonism Relat Disord; 2021 Jun; 87():135-136. PubMed ID: 34034154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Novel
    Imbrici P; Conte E; Blunck R; Stregapede F; Liantonio A; Tosi M; D'Adamo MC; De Luca A; Brankovic V; Zanni G
    Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34576077
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Severe early-onset epileptic encephalopathy due to mutations in the KCNA2 gene: Expansion of the genotypic and phenotypic spectrum.
    Hundallah K; Alenizi A; AlHashem A; Tabarki B
    Eur J Paediatr Neurol; 2016 Jul; 20(4):657-60. PubMed ID: 27117551
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 'North Sea' progressive myoclonus epilepsy: phenotype of subjects with GOSR2 mutation.
    Boissé Lomax L; Bayly MA; Hjalgrim H; Møller RS; Vlaar AM; Aaberg KM; Marquardt I; Gandolfo LC; Willemsen M; Kamsteeg EJ; O'Sullivan JD; Korenke GC; Bloem BR; de Coo IF; Verhagen JM; Said I; Prescott T; Stray-Pedersen A; Rasmussen M; Vears DF; Lehesjoki AE; Corbett MA; Bahlo M; Gecz J; Dibbens LM; Berkovic SF
    Brain; 2013 Apr; 136(Pt 4):1146-54. PubMed ID: 23449775
    [TBL] [Abstract][Full Text] [Related]  

  • 11. KCTD7-related progressive myoclonus epilepsy.
    Van Bogaert P
    Epileptic Disord; 2016 Sep; 18(S2):115-119. PubMed ID: 27629772
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GOSR2: a progressive myoclonus epilepsy gene.
    Dibbens LM; Rubboli G
    Epileptic Disord; 2016 Sep; 18(S2):111-114. PubMed ID: 27618868
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progressive Myoclonus Epilepsy: The Gene-Empowered Era.
    Minassian BA; Striano P; Avanzini G
    Epileptic Disord; 2016 Sep; 18(S2):1-2. PubMed ID: 27694067
    [No Abstract]   [Full Text] [Related]  

  • 14. A detailed description of the phenotypic spectrum of North Sea Progressive Myoclonus Epilepsy in a large cohort of seventeen patients.
    Polet SS; Anderson DG; Koens LH; van Egmond ME; Drost G; Brusse E; Willemsen MA; Sival DA; Brouwer OF; Kremer HP; de Vries JJ; Tijssen MA; de Koning TJ
    Parkinsonism Relat Disord; 2020 Mar; 72():44-48. PubMed ID: 32105965
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel clinical manifestations in patients with KCNA2 mutations.
    Sachdev M; Gaínza-Lein M; Tchapyjnikov D; Jiang YH; Loddenkemper T; Mikati MA
    Seizure; 2017 Oct; 51():74-76. PubMed ID: 28806589
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autosomal recessive progressive myoclonus epilepsy due to impaired ceramide synthesis.
    Ferlazzo E; Striano P; Italiano D; Calarese T; Gasparini S; Vanni N; Fruscione F; Genton P; Zara F
    Epileptic Disord; 2016 Sep; 18(S2):120-127. PubMed ID: 27618929
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adult-onset rapidly worsening progressive myoclonic epilepsy caused by a novel variant in DHDDS.
    Kim S; Kim MJ; Son H; Hwang S; Kang MK; Chu K; Lee SK; Moon J
    Ann Clin Transl Neurol; 2021 Dec; 8(12):2319-2326. PubMed ID: 34837344
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progressive myoclonus epilepsy without renal failure in a Chinese family with a novel mutation in SCARB2 gene and literature review.
    Tian WT; Liu XL; Xu YQ; Huang XJ; Zhou HY; Wang Y; Tang HD; Chen SD; Luan XH; Cao L
    Seizure; 2018 Apr; 57():80-86. PubMed ID: 29605618
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progressive myoclonus epilepsy KCNC1 variant causes a developmental dendritopathy.
    Carpenter JC; Männikkö R; Heffner C; Heneine J; Sampedro-Castañeda M; Lignani G; Schorge S
    Epilepsia; 2021 May; 62(5):1256-1267. PubMed ID: 33735526
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progressive Myoclonus Epilepsy Caused by a Homozygous Splicing Variant of SLC7A6OS.
    Mazzola L; Oliver KL; Labalme A; Baykan B; Muona M; Joensuu TH; Courage C; Chatron N; Borsani G; Alix E; Ramond F; Touraine R; Bahlo M; Bebek N; Berkovic SF; Lehesjoki AE; Lesca G
    Ann Neurol; 2021 Feb; 89(2):402-407. PubMed ID: 33085104
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.